The live attenuated yellow fever virus vaccine (YFV-17D) that confers life-long protective immunity is one of the most effective vaccines ever developed. The knowledge gained from understanding the molecular mechanisms of how this vaccine works will provide the platform to rationally develop new vaccines against emerging diseases including dengue virus that is now a major global epidemic. Project 1 (Ahmed/Wilson) will focus on immune memory, using a novel in vivo labeling technique in humans will measure the homeostasis and longevity of YFV-specific T cells, track the migration of YFV-17D-induced T cells to mucosal sites, and examine the relationship between CD4 T follicular helper cells (TFH) response and the type of antibody produced after both YFV-17D vaccination and dengue infection. Project 2 (Pulendran/Rice) will determine the molecular mechanisms by which the yellow fever vaccine strain YFV-17D and the pathogenic Asibi strain, as well as dengue virus, stimulate innate immunity to program adaptive immune responses. They will also examine a new paradigm of how the immune system can sense viruses by detecting stress signals in the environment, and modulate adaptive immunity. Project 3 (Goronzy) will examine signaling checkpoints that are important for CD4 T cell memory differentiation and that are compromised in the elderly and relate the epigenetic changes to these critical signaling checkpoints, in particular the AMPK and SIRT1 signaling pathways. A great limitation in human vaccine studies is the low frequency of antigen-specific cells and their inherent heterogeneity, which is amplified in the elderly who respond poorly to vaccination. The goal of the Technology Development Project (TDP) (Haining/Greenleaf) is to develop and apply sensitive assays to measure the transcriptional profiles and epigenetic state in rare cell populations or even single cells. This technology will be applied to each of the Research Projects. The human samples for the Research Projects and TDP will be provided by Core C (Mulligan/Yu/Chokephaibulkit) which is located at two sites: 1) The Emory Hope Clinic where volunteers will be enrolled into the YFV-17D studies. 2) Dengue Clinical Unit, at Siriraj Hospital, Bangkok, Thailand where dengue infected patients will be enrolled.

Public Health Relevance

Vaccines are one of the most cost-effective weapons to prevent infectious diseases and protect public health. A better understanding of the fundamental immunological mechanisms that constitute one of world's most effective vaccines (YFV-17D) would guide the rational design of future vaccines, including for the increasing elderly population. Dengue infection is a global epidemic, understanding the innate and adaptive immune responses to dengue infection would lead to the development of a much needed vaccine.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI057266-11
Application #
8709050
Study Section
Special Emphasis Panel (ZAI1-LAR-I (J1))
Program Officer
Quill, Helen R
Project Start
2003-09-01
Project End
2019-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
11
Fiscal Year
2014
Total Cost
$2,884,146
Indirect Cost
$714,275
Name
Emory University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Hohensinner, Philipp J; Goronzy, Jörg J; Weyand, Cornelia M (2014) Targets of immune regeneration in rheumatoid arthritis. Mayo Clin Proc 89:563-75
Suthar, Mehul S; Pulendran, Bali (2014) Systems analysis of West Nile virus infection. Curr Opin Virol 6:70-5
Pulendran, Bali (2014) Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A 111:12300-6
Janssens, Sophie; Pulendran, Bali; Lambrecht, Bart N (2014) Emerging functions of the unfolded protein response in immunity. Nat Immunol 15:910-9
Kwissa, Marcin; Nakaya, Helder I; Onlamoon, Nattawat et al. (2014) Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe 16:115-27
Weyand, Cornelia M; Yang, Zhen; Goronzy, Jorg J (2014) T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26:93-100
Yang, Rendong; Bai, Yun; Qin, Zhaohui et al. (2014) EgoNet: identification of human disease ego-network modules. BMC Genomics 15:314
Burke, Rachel M; Smith, Emily R; Dahl, Rebecca Moritz et al. (2014) The economic burden of pediatric gastroenteritis to Bolivian families: a cross-sectional study of correlates of catastrophic cost and overall cost burden. BMC Public Health 14:642
Chiu, Christopher; McCausland, Megan; Sidney, John et al. (2014) Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog 10:e1004008
Jagger, Ann; Shimojima, Yasuhiro; Goronzy, Jorg J et al. (2014) Regulatory T cells and the immune aging process: a mini-review. Gerontology 60:130-7

Showing the most recent 10 out of 127 publications